Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides
- Autores
- Alza, Natalia Paola; Pirker, Teresa; Pferschy Wenzig, Eva María; Bauer, Rudolf; Salvador, Gabriela Alejandra
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Chronic inflammation is considered a common pathological mech- anism in many diseases including cancer, heart disease, diabetes, arthritis, and neurodegenerative disorders. Combating inflammation with plants and natural compounds is thought to be a strategy for replacing current therapy that causes severe side effects. The aim of our work was to study the anti- inflammatory properties of bioac- tive constituents from the aqueous extract of Cyclolepis genistoides D. Don (Asteraceae). This plant has been used in folk medicine in northern and central Argentina for bone pain (analgesic properties) and as a diuretic in kidney diseases. The metabolite analysis of the aqueous extract by LC-HRMS revealed the presence of coumarins (isofraxidin, fraxetin), phenolic compounds (caffeoylquinic acids and their sulfate derivatives, luteolin and its glucuronide, luteolin-7-sul- fate) and two sesquiterpene lactones, deacylcynaropicrin (DACP) and its 11,13-dihydro derivative (DH-DACP). In our lab, we previous- ly demonstrated the ability of C. genistoides and DACP to modulate the transcription factor NFμB by blocking its nuclear translocation. To gain more insight in the anti-inflammatory potential, the pharma- cological activity was also evaluated in other inflammation-related cellular in vitro models. We found that DACP (20 μM) inhibited not only NFμB1 but also COX-2 gene expression in PMA-differentiated and LPS-stimulated THP-1 cells. In addition, nitric oxide production was inhibited by DACP in microglial BV-2 cells exposed to LPS and IFN-γ (IC50 = 10.4 +/- 0.7 μM). However, DH-DACP (20 μM) had no effect on the studied pro-inflammatory pathways. The difference in pharmacological properties of both sesquiterpene lactones could be explained by the Michael acceptor moiety present in the DACP structure. Taken together, we hypothesize that DACP could be a lead compound for the development of anti-inflammatory agents due to its ability to inhibit NFκB pathway.
Fil: Alza, Natalia Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Química; Argentina
Fil: Pirker, Teresa. University of Graz; Austria
Fil: Pferschy Wenzig, Eva María. University of Graz; Austria
Fil: Bauer, Rudolf. University of Graz; Austria
Fil: Salvador, Gabriela Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina
LXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Mar del Plata
Argentina
Sociedad Argentina de Investigación Clínica
Sociedad Argentina de Biología
Asociación Argentina de Farmacología Experimental
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio - Materia
-
Anti-inflammatory activity
Deacylcinapropicrin
NFkB - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/232420
Ver los metadatos del registro completo
id |
CONICETDig_641bc72d71be8bd31d6e0c32f24d5292 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/232420 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoidesAlza, Natalia PaolaPirker, TeresaPferschy Wenzig, Eva MaríaBauer, RudolfSalvador, Gabriela AlejandraAnti-inflammatory activityDeacylcinapropicrinNFkBhttps://purl.org/becyt/ford/1.4https://purl.org/becyt/ford/1Chronic inflammation is considered a common pathological mech- anism in many diseases including cancer, heart disease, diabetes, arthritis, and neurodegenerative disorders. Combating inflammation with plants and natural compounds is thought to be a strategy for replacing current therapy that causes severe side effects. The aim of our work was to study the anti- inflammatory properties of bioac- tive constituents from the aqueous extract of Cyclolepis genistoides D. Don (Asteraceae). This plant has been used in folk medicine in northern and central Argentina for bone pain (analgesic properties) and as a diuretic in kidney diseases. The metabolite analysis of the aqueous extract by LC-HRMS revealed the presence of coumarins (isofraxidin, fraxetin), phenolic compounds (caffeoylquinic acids and their sulfate derivatives, luteolin and its glucuronide, luteolin-7-sul- fate) and two sesquiterpene lactones, deacylcynaropicrin (DACP) and its 11,13-dihydro derivative (DH-DACP). In our lab, we previous- ly demonstrated the ability of C. genistoides and DACP to modulate the transcription factor NFμB by blocking its nuclear translocation. To gain more insight in the anti-inflammatory potential, the pharma- cological activity was also evaluated in other inflammation-related cellular in vitro models. We found that DACP (20 μM) inhibited not only NFμB1 but also COX-2 gene expression in PMA-differentiated and LPS-stimulated THP-1 cells. In addition, nitric oxide production was inhibited by DACP in microglial BV-2 cells exposed to LPS and IFN-γ (IC50 = 10.4 +/- 0.7 μM). However, DH-DACP (20 μM) had no effect on the studied pro-inflammatory pathways. The difference in pharmacological properties of both sesquiterpene lactones could be explained by the Michael acceptor moiety present in the DACP structure. Taken together, we hypothesize that DACP could be a lead compound for the development of anti-inflammatory agents due to its ability to inhibit NFκB pathway.Fil: Alza, Natalia Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Química; ArgentinaFil: Pirker, Teresa. University of Graz; AustriaFil: Pferschy Wenzig, Eva María. University of Graz; AustriaFil: Bauer, Rudolf. University of Graz; AustriaFil: Salvador, Gabriela Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; ArgentinaLXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de LaboratorioMar del PlataArgentinaSociedad Argentina de Investigación ClínicaSociedad Argentina de BiologíaAsociación Argentina de Farmacología ExperimentalAsociación Argentina de Ciencia y Tecnología de Animales de LaboratorioFundación Revista Medicina2023info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónJournalhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/232420Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides; LXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2023; 218-2180025-76801669-9106CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://medicinabuenosaires.com/revistas/vol83-23/s5/1s5.pdfNacionalinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:23:38Zoai:ri.conicet.gov.ar:11336/232420instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:23:39.065CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
title |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
spellingShingle |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides Alza, Natalia Paola Anti-inflammatory activity Deacylcinapropicrin NFkB |
title_short |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
title_full |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
title_fullStr |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
title_full_unstemmed |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
title_sort |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides |
dc.creator.none.fl_str_mv |
Alza, Natalia Paola Pirker, Teresa Pferschy Wenzig, Eva María Bauer, Rudolf Salvador, Gabriela Alejandra |
author |
Alza, Natalia Paola |
author_facet |
Alza, Natalia Paola Pirker, Teresa Pferschy Wenzig, Eva María Bauer, Rudolf Salvador, Gabriela Alejandra |
author_role |
author |
author2 |
Pirker, Teresa Pferschy Wenzig, Eva María Bauer, Rudolf Salvador, Gabriela Alejandra |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Anti-inflammatory activity Deacylcinapropicrin NFkB |
topic |
Anti-inflammatory activity Deacylcinapropicrin NFkB |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.4 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Chronic inflammation is considered a common pathological mech- anism in many diseases including cancer, heart disease, diabetes, arthritis, and neurodegenerative disorders. Combating inflammation with plants and natural compounds is thought to be a strategy for replacing current therapy that causes severe side effects. The aim of our work was to study the anti- inflammatory properties of bioac- tive constituents from the aqueous extract of Cyclolepis genistoides D. Don (Asteraceae). This plant has been used in folk medicine in northern and central Argentina for bone pain (analgesic properties) and as a diuretic in kidney diseases. The metabolite analysis of the aqueous extract by LC-HRMS revealed the presence of coumarins (isofraxidin, fraxetin), phenolic compounds (caffeoylquinic acids and their sulfate derivatives, luteolin and its glucuronide, luteolin-7-sul- fate) and two sesquiterpene lactones, deacylcynaropicrin (DACP) and its 11,13-dihydro derivative (DH-DACP). In our lab, we previous- ly demonstrated the ability of C. genistoides and DACP to modulate the transcription factor NFμB by blocking its nuclear translocation. To gain more insight in the anti-inflammatory potential, the pharma- cological activity was also evaluated in other inflammation-related cellular in vitro models. We found that DACP (20 μM) inhibited not only NFμB1 but also COX-2 gene expression in PMA-differentiated and LPS-stimulated THP-1 cells. In addition, nitric oxide production was inhibited by DACP in microglial BV-2 cells exposed to LPS and IFN-γ (IC50 = 10.4 +/- 0.7 μM). However, DH-DACP (20 μM) had no effect on the studied pro-inflammatory pathways. The difference in pharmacological properties of both sesquiterpene lactones could be explained by the Michael acceptor moiety present in the DACP structure. Taken together, we hypothesize that DACP could be a lead compound for the development of anti-inflammatory agents due to its ability to inhibit NFκB pathway. Fil: Alza, Natalia Paola. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Química; Argentina Fil: Pirker, Teresa. University of Graz; Austria Fil: Pferschy Wenzig, Eva María. University of Graz; Austria Fil: Bauer, Rudolf. University of Graz; Austria Fil: Salvador, Gabriela Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Bahía Blanca. Instituto de Investigaciones Bioquímicas de Bahía Blanca. Universidad Nacional del Sur. Instituto de Investigaciones Bioquímicas de Bahía Blanca; Argentina. Universidad Nacional del Sur. Departamento de Biología, Bioquímica y Farmacia; Argentina LXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio Mar del Plata Argentina Sociedad Argentina de Investigación Clínica Sociedad Argentina de Biología Asociación Argentina de Farmacología Experimental Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio |
description |
Chronic inflammation is considered a common pathological mech- anism in many diseases including cancer, heart disease, diabetes, arthritis, and neurodegenerative disorders. Combating inflammation with plants and natural compounds is thought to be a strategy for replacing current therapy that causes severe side effects. The aim of our work was to study the anti- inflammatory properties of bioac- tive constituents from the aqueous extract of Cyclolepis genistoides D. Don (Asteraceae). This plant has been used in folk medicine in northern and central Argentina for bone pain (analgesic properties) and as a diuretic in kidney diseases. The metabolite analysis of the aqueous extract by LC-HRMS revealed the presence of coumarins (isofraxidin, fraxetin), phenolic compounds (caffeoylquinic acids and their sulfate derivatives, luteolin and its glucuronide, luteolin-7-sul- fate) and two sesquiterpene lactones, deacylcynaropicrin (DACP) and its 11,13-dihydro derivative (DH-DACP). In our lab, we previous- ly demonstrated the ability of C. genistoides and DACP to modulate the transcription factor NFμB by blocking its nuclear translocation. To gain more insight in the anti-inflammatory potential, the pharma- cological activity was also evaluated in other inflammation-related cellular in vitro models. We found that DACP (20 μM) inhibited not only NFμB1 but also COX-2 gene expression in PMA-differentiated and LPS-stimulated THP-1 cells. In addition, nitric oxide production was inhibited by DACP in microglial BV-2 cells exposed to LPS and IFN-γ (IC50 = 10.4 +/- 0.7 μM). However, DH-DACP (20 μM) had no effect on the studied pro-inflammatory pathways. The difference in pharmacological properties of both sesquiterpene lactones could be explained by the Michael acceptor moiety present in the DACP structure. Taken together, we hypothesize that DACP could be a lead compound for the development of anti-inflammatory agents due to its ability to inhibit NFκB pathway. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Reunión Journal http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/232420 Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides; LXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2023; 218-218 0025-7680 1669-9106 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/232420 |
identifier_str_mv |
Anti-inflammatory properties of deacilcinaropicrin from Cyclolepis genistoides; LXVIII Reunión Anual de la Sociedad Argentina de Investigación Clínica; XXV Jornadas Anuales de la Sociedad Argentina de Biología; LV Reunión Anual de la Asociación Argentina de Farmacología Experimental y VIII Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2023; 218-218 0025-7680 1669-9106 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://medicinabuenosaires.com/revistas/vol83-23/s5/1s5.pdf |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.coverage.none.fl_str_mv |
Nacional |
dc.publisher.none.fl_str_mv |
Fundación Revista Medicina |
publisher.none.fl_str_mv |
Fundación Revista Medicina |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846082649418891264 |
score |
13.22299 |